A rosszindulatú heredaganatok komplex kezelése.

Translated title of the contribution: Combined therapy of malignant testicular tumors

J. Pintér, I. Bodrogi, J. G. Pintér, V. Szokoly, L. Korányi, S. Eckhardt

Research output: Contribution to journalReview article

1 Citation (Scopus)


The 5-year survival of patients with malignant testicular tumors rose during the past 25 years from 10-25% depending on stage to 55-100% after radical castration performed from high inguinal opening, retroperitoneal lymphadenectomy, ultra-tension irradiation and adjuvant chemotherapy. It is stressed that patients diagnosed at stage T1-2, N0-2, M0 may even recover perfectly upon complex therapy. Three to five-year long or even longer survival may be reached with 50% of the patients at the stage T1-3, N1-3, M1. Patients at stage T4, N3-4, M1 die because of the recurrence of the tumor and/or the complication of the adjuvant treatment within 1-3 years and even the interdisciplinary work which is very effective in other stages fails to change this at the present time.

Original languageHungarian
Pages (from-to)271-275
Number of pages5
JournalOrvosi hetilap
Issue number6
Publication statusPublished - Feb 12 1989


ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pintér, J., Bodrogi, I., Pintér, J. G., Szokoly, V., Korányi, L., & Eckhardt, S. (1989). A rosszindulatú heredaganatok komplex kezelése. Orvosi hetilap, 130(6), 271-275.